(4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-dimethyl-2-oxo-N-phenylhexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide

ID: ALA4064645

PubChem CID: 10500864

Max Phase: Preclinical

Molecular Formula: C25H34N2O2

Molecular Weight: 394.56

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@]12CCC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3ccccc3)CC[C@@H]12

Standard InChI:  InChI=1S/C25H34N2O2/c1-24-14-12-19-17(8-11-21-25(19,2)15-13-22(28)27-21)18(24)9-10-20(24)23(29)26-16-6-4-3-5-7-16/h3-7,17-21H,8-15H2,1-2H3,(H,26,29)(H,27,28)/t17-,18-,19-,20+,21+,24-,25+/m0/s1

Standard InChI Key:  CXCHAQSCCCXEAH-QKONGSNMSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    3.4875   -8.1265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4875   -8.9437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1928   -9.3482    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1928   -7.7138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8981   -8.1265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8946   -8.9437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5967   -9.3530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3067   -8.9497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6036   -7.7187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3102   -8.1373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3271   -6.4977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6089   -6.8996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0336   -6.9163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0203   -7.7350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7949   -8.0007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2869   -7.3462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8164   -6.6761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0287   -6.0959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0815   -5.9031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7804   -9.3533    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8908   -7.3093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3023   -7.3176    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.5965   -8.5351    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    7.0122   -8.5516    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.8866   -9.7568    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    8.8835   -5.7462    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5446   -5.2870    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4204   -6.3623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1511   -7.1326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6872   -7.7484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4901   -7.5917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7541   -6.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2163   -6.2015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9 10  1  0
  9 12  1  0
 10 14  1  0
 13 11  1  0
 11 12  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 13 18  1  1
 17 19  1  1
  2 20  2  0
  5 21  1  1
 10 22  1  1
  9 23  1  6
 14 24  1  6
  6 25  1  6
 19 26  1  0
 19 27  2  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
M  END

Associated Targets(Human)

SRD5A1 Tclin Steroid 5-alpha-reductase 1 (755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRD5A2 Tclin Steroid 5-alpha-reductase 2 (937 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.56Molecular Weight (Monoisotopic): 394.2620AlogP: 4.76#Rotatable Bonds: 2
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.90CX Basic pKa: CX LogP: 4.04CX LogD: 4.04
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.76Np Likeness Score: 0.71

References

1. Lao K, Sun J, Wang C, Wang Y, You Q, Xiao H, Xiang H..  (2017)  Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.,  27  (17): [PMID:28757062] [10.1016/j.bmcl.2017.05.078]

Source